This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Giuliani International Limited. Active years: 2010.
Company Filing History:
Years Active: 2010
Title: Rainer Apfel: Innovator in CNS Disease Treatment
Introduction
Rainer Apfel is a notable inventor based in Sinzing, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of central nervous system (CNS) diseases. His innovative work has led to the development of a specific inhibitor that holds promise for improving patient outcomes.
Latest Patents
Rainer Apfel holds 1 patent for his invention titled "SMAD7 inhibitors for the treatment of CNS diseases." This patent focuses on the use of a specific inhibitor of Smad7 expression or function for the preparation of a pharmaceutical composition aimed at preventing, ameliorating, or treating diseases of the central nervous system. The invention also discloses methods for preventing and treating such diseases, showcasing its potential impact on medical science.
Career Highlights
Rainer Apfel is associated with Giuliani International Limited, where he continues to advance his research and development efforts. His work is characterized by a commitment to addressing complex medical challenges through innovative solutions.
Collaborations
Rainer has collaborated with notable colleagues, including Ingo Kleiter and Andreas Steinbrecher. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries in the field of CNS disease treatment.
Conclusion
Rainer Apfel's contributions to the field of pharmaceuticals, particularly through his patent on SMAD7 inhibitors, highlight his role as an innovator in the treatment of CNS diseases. His work continues to inspire advancements in medical research and patient care.